A more immunosuppressive pre-transplant conditioning may be required for Chinese patients with thalassaemia

Bone Marrow Transplantation

Volumn 17, Issue 6, 1996, Pages 907-910

  Shing, M M K ^a   Yuen, P M P ^a   Li, C K ^a   Chik, K W ^a   Lai, H D H ^a   Tsang, K S ^a   Ng, M H L ^a   Tsoi, W C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Allogeneic; Chinese; Thalassaemia

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HEMOGLOBIN H; METHOTREXATE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHINESE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SEPTICEMIA; SIBLING; SURVIVAL RATE; THALASSEMIA MAJOR; TRANSFUSION; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; MALE; SURVIVAL RATE; THALASSEMIA; TRANSPLANTATION CONDITIONING;

EID: 0030058441     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ehlers KH, Giardina PJ, Lesser ML. Prolonged survival in patients with beta-thalassaemia major treated with desferrioxamine. J Pediatrics 1991; 118: 540-545.
2. Barbara JAJ, Contreras M. Infectious complications of blood transfusion: virsues. Br Med J 1990; 300: 450-453.
3. Lucarelli G, Clift RA. Bone marrow transplantation in thalassaemia. In: Foreman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific Publication: USA 1994, pp 829-839.
4. Thomas ED, Bucker CD, Sanders JE. Marrow transplantation for thalassaemia. Lancet 1982; 2: 227-229.
5. Lucarelli G, Galimberti M, Polchi P. Marrow transplantation in patients with advanced thalassaemia. New Engl J Med 1987; 316: 1050-1055.
6. Lucarelli G, Galimberti M, Polchi P. Bone marrow transplantation in patients with thalassaemia. New Engl J Med 1990; 322: 417-421.
7. Lucarelli G, Galimberti M, Polchi P. Marrow transplantation in patients with thalassaemia responsive to iron chelation therapy. New Engl J Med 1993; 329: 840-844.
8. Issaragrisil S, Visudhisakchai S, Suvatte V. BMT for thalassaemia in Thailand. Bone Marrow Transplant 1993; 12 (Suppl): 42-44.
9. Lin KH, Lin KS. Allogeneic BMT for thallassaemia in Taiwan: factors associated with graft failure. Am J Pediatr Hematol Oncol 1989; 11: 417-423.
10. Lee ACW, Lau YL, Chan CF. Bone marrow transplantation for thalassaemia: a high rejection rate in Chinese children? 20th Annual Meeting European Group for Bone Marrow Transplantation and 10th Meeting of the Nurses Group, 13-17 March 1994, abstract 426.
11. Lin KH, Lin KS. Results of therapy for beta-thalassaemia major. J Formosan Med Assoc 1992; 91: 126-130.
12. Lee ACW, Lau YL, Chan CF. Bone marrow transplantation for thalassaemia in Hong Kong: the early experience. Bone Marrow Transplant 1993; 12 (Suppl. 1): 49-50.
13. Issaragrisil S, Visuthisakchai S, Suvatte V. Transplantation of cord blood stem cells into a patient with severe thalassaemia. New Engl J Med 1995; 332: 367-369.